Trial Profile
Comprehensive Evaluation of Right Ventricular Function, Ventricular Remodeling and Micro RNA Profiling in Pulmonary Artery Hypertension: Effects of a Fatty Acid Oxidation Inhibitor
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Trimetazidine (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 26 Jun 2014 New trial record